---
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/100000000979622.md"
description: "$Hims & Hers Health(HIMS.US) | Canaccord 𝗿𝗲𝗶𝘁𝗲𝗿𝗮𝘁𝗲𝘀 𝗕𝘂𝘆 on 𝗛𝗶𝗺𝘀 & 𝗛𝗲𝗿𝘀 𝗛𝗲𝗮𝗹𝘁𝗵, maintains PT at $𝟰𝟬Analyst sees an improving Q1 setup as weight-loss offerings expand and international markets and newer specialties sustain momentum."
datetime: "2026-11-10T11:52:22.000Z"
locales:
  - [en](https://longbridge.com/en/topics/100000000979622.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/100000000979622.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/100000000979622.md)
author: "[Hardik Shah](https://longbridge.com/en/profiles/27423834.md)"
generator: "portal-rs"
---

# $Hims & Hers Health(HIMS.US) | Canaccord 𝗿𝗲𝗶𝘁𝗲…


### Related Stocks

- [HIMS.US](https://longbridge.com/en/quote/HIMS.US.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**